Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256758 | SCV001433169 | likely benign | not specified | 2019-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002370043 | SCV002685617 | uncertain significance | Cardiovascular phenotype | 2019-06-17 | criteria provided, single submitter | clinical testing | The p.F4246V variant (also known as c.12736T>G), located in coding exon 29 of the APOB gene, results from a T to G substitution at nucleotide position 12736. The phenylalanine at codon 4246 is replaced by valine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002535534 | SCV003325581 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-01-08 | criteria provided, single submitter | clinical testing |